FLORHAM PARK, N.J., March 14, 2024 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused […]
Initial order received for thirty of omniQ’s Kiosks. Enabling omniQ’s Fintech payment solution and its quick Taxi reservation functionality. omniQ’s […]
Company advancing an innovative pipeline of NKT cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases Ongoing efforts […]